Quick verdict
Strut Health is the better pick for most patients on overall scoring. One of the cheapest legitimate compounded options in the US market thanks to a niche oral lozenge format. No membership fee, free shipping, free consults, and physician access included. Trade-off: lozenge bioavailability data is thin compared to standard injectable semaglutide.
That said, Eden wins on specific dimensions. Eden is the highest-volume compounded-only brand outside Henry. Slick funnel, low intro pricing, lots of upsell. Quality of clinical experience is thinner than Henry or Ivim and cancellation is the most common complaint thread.
Side-by-side
| Eden | Strut Health | |
|---|---|---|
| Starts from | $179/mo (incl. medication) | $99/mo (incl. medication) |
| Lock-in | 3-month minimum | Month-to-month |
| Time to prescription | 2 days | 3 days |
| Consultation type | Asynchronous | Async |
| Affiliate network | Impact | Direct |
Score by dimension
Five dimensions, ten points each. The winner of each dimension is highlighted.
| Eden | Strut Health | |
|---|---|---|
| Pricing transparency | 7/10 | 9/10 |
| Cancellation terms | 5/10 | 9/10 |
| Onboarding experience | 8/10 | 7/10 |
| Medication options | 5/10 | 6/10 |
| Member outcomes | 6/10 | 6/10 |
When to choose Eden
Price-led buyers willing to navigate a heavier upsell flow for an aggressive intro price.
When to choose Strut Health
Cost-sensitive patients who want needle-free GLP-1 entry under $100/mo and don't mind a less-studied delivery format.
FAQ
Is Eden cheaper than Strut Health?
Can I switch from Eden to Strut Health mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart →